Advanced Science, 2023 · DOI: https://doi.org/10.1002/advs.202205641 · Published: March 12, 2023
Bacteria-mediated antitumor therapy provides new options to address challenges in cancer treatment by destroying tumor cells from the inside and inducing antitumor immune responses. Bacteria and their accessory products can be reprogrammed to produce and deliver antitumor agents according to clinical needs. BMAT has many advantages including tumor targeting, intratumoral penetration, tumor colonization, and bacterial cytotoxicity for tumor killing.
Engineered bacteria can be used to deliver drugs with spatial and temporal precision, enabling higher concentrations of therapeutics locally.
Bacteria-based therapies can be combined with chemotherapy, photodynamic therapy, radiotherapy, and immunotherapy to improve antitumor efficacy.
Bacterial therapies can be personalized through genetic engineering and biochemical synthesis to meet specific clinical therapeutic requirements.